Erratum: Rewards of beauty: The opioid system mediates social motivation in humans (Molecular Psychiatry (2014) 19 (746-747) DOI:10.1038/mp.2014.1);Rewards of beauty: The opioid system mediates social motivation in humans

Molecular Psychiatry

Volumn 19, Issue 7, 2014, Pages 746-747

  Chelnokova, O ^a   Laeng, B ^a   Eikemo, M ^a   Riegels, J ^a   Loseth G ^a   Maurud, H ^a   Willoch, F ^a   Leknes, S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NALTREXONE; OPIATE RECEPTOR; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LETTER; MALE; MOTIVATION; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; REWARD; TASK PERFORMANCE; VISUAL ANALOG SCALE; AGONISTS; ANTAGONISTS AND INHIBITORS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECTS; ESTHETICS; FACE; PHOTOSTIMULATION; PHYSIOLOGY;

ANALGESICS, OPIOID; BEAUTY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FACE; HUMANS; MALE; MORPHINE; MOTIVATION; NALTREXONE; NARCOTIC ANTAGONISTS; PHOTIC STIMULATION; RECEPTORS, OPIOID, MU; REWARD;

EID: 84903581510     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.149     Document Type: Erratum

References (15)

1. Perrett DI, Lee KJ, Penton-Voak I, Rowland D, Yoshikawa S, Burt DM et al. Nature 1998; 394: 884-887.
2. Rhodes G, Simmons LW, Peters M. Evol Hum Behav 2005; 26: 186-201.
3. Parsons CE, Young KS, Mohseni H, Woolrich MW, Thomsen KR, Joensson M et al. Soc Neurosci-Uk 2013; 8: 268-274.
4. Dion K, Walster E, Berschei. E. J Pers Soc Psychol 1972; 24: 285-289.
5. Langlois JH, Kalakanis L, Rubenstein AJ, Larson A, Hallam M, Smoot M. Psychol Bull 2000; 126: 390-423.
6. Aharon I, Etcoff N, Ariely D, Chabris CF, O'Connor E, Breiter HC. Neuron 2001; 32: 537-551.
7. Hayden BY, Parikh PC, Deaner RO, Platt ML. Proc Biol Sci 2007; 274: 1751-1756.
8. Biederman I, Vessel EA. Am Sci 2006; 94: 247-253.
9. Nelson EE, Panksepp J. Neurosci Biobehav Rev 1998; 22: 437-452.
10. Machin AJ, Dunbar RIM. Behaviour 2011; 148: 985-1025.
11. Hsu DT, Sanford BJ, Meyers KK, Love TM, Hazlett KE, Wang H et al. Mol psychiatry 2013; 18: 1211-1217.
12. Berridge KC, Kringelbach ML. Psychopharmacology 2008; 199: 457-480.
13. Cooper SJ, Turkish S. Pharmacol Biochem Be 1989; 33: 17-20.
14. Mahler SV, Berridge KC. Psychopharmacology 2012; 221: 407-426.
15. Parsons CE, Young KS, Kumari N, Stein A, Kringelbach ML. Plos ONE 2011; 6: e20632.